William Shakespeare - President of Research and Development at Theseus Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President of Research and Development
Issuer Symbol
THRX
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by William Shakespeare since 11 Mar 2025

Holdings reported by William Shakespeare for Theseus Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 639,408 $1,950,194 $3.05 06 Nov 2023 Direct
Restricted Stock Units 21,250 $64,813 $3.05 01 Mar 2023 Direct Common Stock
Stock Option (right to buy) 93,260 06 Nov 2023 Direct Common Stock

Transactions reported by William Shakespeare for Theseus Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.